Published in Int Psychogeriatr on May 14, 2007
The Mini-Mental State Exam (MMSE) is not sensitive to cognitive impairment in bariatric surgery candidates. Surg Obes Relat Dis (2013) 1.40
The role of B vitamins in preventing and treating cognitive impairment and decline. Adv Nutr (2012) 1.18
Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J Am Geriatr Soc (2012) 0.96
Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings. Dement Geriatr Cogn Disord (2008) 0.96
Posterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairment. J Alzheimers Dis (2012) 0.92
Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain (2016) 0.90
Assessment of mild cognitive impairment with mini mental state examination among adults in southeast Nigeria. Ann Med Health Sci Res (2012) 0.88
Separate physical tests of lower extremities and postural control are associated with cognitive impairment. Results from the general population study Good Aging in Skåne (GÅS-SNAC). Clin Interv Aging (2012) 0.87
Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls. Front Aging Neurosci (2014) 0.83
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials. J Neurol Neurosurg Psychiatry (2016) 0.82
Cause of death in mild cognitive impairment: a prospective study (NEDICES). Eur J Neurol (2013) 0.82
Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. Clinics (Sao Paulo) (2009) 0.81
Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment. Front Aging Neurosci (2014) 0.81
Associations of cumulative Pb exposure and longitudinal changes in Mini-Mental Status Exam scores, global cognition and domains of cognition: The VA Normative Aging Study. Environ Res (2016) 0.75
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry (2007) 1.95
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging (2009) 1.46
Post-operative delirium is associated with poor cognitive outcome and dementia. Dement Geriatr Cogn Disord (2006) 1.17
Performance of a Brazilian population on the test of functional health literacy in adults. Rev Saude Publica (2009) 1.07
Aging and memory control beliefs: performance in relation to goal setting and memory self-evaluation. J Gerontol B Psychol Sci Soc Sci (2004) 1.01
Reduced serum nerve growth factor in patients with late-life depression. Am J Geriatr Psychiatry (2013) 0.98
Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr (2008) 0.97
Alzheimer's disease. Subcell Biochem (2012) 0.95
Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Med (2012) 0.93
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett (2011) 0.93
Neuropsychiatric symptoms in the prodromal stages of dementia. Curr Opin Psychiatry (2014) 0.93
Reduced serum levels of adiponectin in elderly patients with major depression. J Psychiatr Res (2012) 0.92
Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry (2012) 0.90
CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. Int J Geriatr Psychiatry (2008) 0.89
Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Rev Bras Psiquiatr (2010) 0.88
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) (2008) 0.86
Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res (2011) 0.86
Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease. Clinics (Sao Paulo) (2011) 0.84
The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. Int Psychogeriatr (2005) 0.83
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.83
Cognitive training increases platelet PLA2 activity in healthy elderly subjects. Prostaglandins Leukot Essent Fatty Acids (2008) 0.82
Mild cognitive impairment: a concept ready to move on? Curr Opin Psychiatry (2008) 0.82
[Treatment of Alzheimer's disease: recommendations and suggestions of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology]. Arq Neuropsiquiatr (2005) 0.82
Assessment of balance in mild and moderate stages of Alzheimer's disease: implications on falls and functional capacity. Arq Neuropsiquiatr (2011) 0.82
Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. Clinics (Sao Paulo) (2009) 0.81
Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds. Arch Clin Neuropsychol (2009) 0.81
Language and visuospatial impairment in a case of crossed aphasia. Laterality (2006) 0.80
Prevalence of potentially reversible dementias in a dementia outpatient clinic of a tertiary university-affiliated hospital in Brazil. Arq Neuropsiquiatr (2004) 0.79
Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons. Prostaglandins Leukot Essent Fatty Acids (2009) 0.79
Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. Psychopharmacology (Berl) (2005) 0.78
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology (Berl) (2007) 0.78
Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype. Clinics (Sao Paulo) (2013) 0.78
Platelet biomarkers in Alzheimer's disease. World J Psychiatry (2012) 0.78
Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study. J Neural Transm (Vienna) (2013) 0.78
Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adults. Arch Clin Neuropsychol (2009) 0.78
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77
Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. J Neural Transm (Vienna) (2011) 0.77
Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations. Curr Alzheimer Res (2016) 0.76
Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders. Curr Opin Psychiatry (2011) 0.76
Language impairment in Huntington's disease. Arq Neuropsiquiatr (2012) 0.76
Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. J Psychiatr Res (2012) 0.76
A radioenzymatic assay to identify three groups of phospholipase A(2) in platelets. Prostaglandins Leukot Essent Fatty Acids (2012) 0.75
Drs Aprahamian and Forlenza reply. J Clin Psychiatry (2015) 0.75
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. J Psychiatr Res (2012) 0.75
Cognitive impairment and dementia in late-life bipolar disorder. Curr Opin Psychiatry (2013) 0.75
Impairment of inferential abilities based on pictorial stimuli in patients with right-hemisphere damage. Appl Neuropsychol Adult (2014) 0.75